Other · developed by ASTRAZENECA
Formulation 4 (AZD9550) is a solution for injection given as a single subcutaneous injection. It is studied in healthy participants.
Summary written with AI from the sources listed at the end of this page.
Healthy Participants
Updated Nov 8, 2026. Something wrong or missing? Report it on the AZN page.
See AZN's upcoming FDA decisions, trial readouts, cash runway and dilution risk, updated every day from SEC, FDA and ClinicalTrials.gov filings.
AZN catalysts and pipeline →